• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medical device execs find ally in HHS chief Price on medtech tax

Medical device execs find ally in HHS chief Price on medtech tax

June 20, 2017 By Brad Perriello

Medical device taxThe covey of medical device executives that alit on Capitol Hill last week to lobby for repealing the medtech tax and getting a new user fee deal with the FDA in place reportedly found a ready ally in Dr. Tom Price, head of the U.S. Health & Human Services Dept.

More than 50 medical device company officials met with dozens of legislators and federal officials June 15, pressing for a repeal of the 2.3% tax on U.S. medtech sales enacted as part of Obamacare. Although the tax is currently in abeyance, it’s set to go back into effect next year.

Price told the execs, who were on The Hill under the auspices of AdvaMed, that the Trump administration has every reason to admire medtech for the job creation and innovation it generates, the Washington Post reported.

Saying he was “adamantly opposed” to the medical device tax as a Republican representative for a district in Georgia during the negotiations over Obamacare, Price said the levy doesn’t make sense and impedes innovation, “sources in the room” told the newspaper.

Although the House version of the Trumpcare bill would abolish the medical device tax, the group of senators negotiating the Upper Chamber version behind closed doors is said to be mulling the retention of some Obamacare taxes.

Price is likely less receptive to the industry’s hopes for the user fee deal with the FDA, given the administration’s plan to double user fees to $2.4 billion in a bid to lower taxpayer funding of the federal safety watchdog.

“There’s been some less than helpful messaging from the White House in terms of how they want to approach that,” J.C. Scott, AdvaMed’s chief advocacy officer & external affairs head, told Morning Consult. “Any time slippage that we see on The Hill in terms of getting that legislation done causes us concern.”

Filed Under: Regulatory/Compliance Tagged With: Capitol Hill, medicaldevicetax, User fees

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy